The India pharma industry moves beyond generics to enter new global markets. Karl Reilly
India pharma looking to capitalize on existing strengths and attract CRAMS. Jan Schmidt-Whitley
GBR Connect Series
Political change could vault India’s pharmaceuticals market to new heights. Karl O’Raghallaigh
CPhI, Global Business Reports (GBR) launching comprehensive study of Indian pharmaceuticals market. CPhI
Signet is India’s largest excipient company with extensive activities extending to Bangladesh and the Middle East.